Brief: FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device
22/02/2024 14:44
Feb 22 (Reuters) - SeaStar Medical Holding Corp ICU.O :
* FDA GRANTS HUMANITARIAN DEVICE EXEMPTION APPROVAL TO
SEASTAR
MEDICAL’S SELECTIVE CYTOPHERETIC DEVICE FOR PEDIATRIC ACUTE
KIDNEY INJURY
Source text for Eikon: ID:nGNX5s9K3
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview